Indian Journal of Critical Care Medicine · 2016 · 37 citations · 19 references
A high utilization of AMAs and a high cost of treatment were noticed which was comparable to other published data, though an increased use of newer AMAs such as linezolid, clindamycin, meropenem, colistin was noticed.
19